New IRB for Military Cancer Research Offers One-Stop Shop

by U.S. Medicine

May 20, 2011

WASHINGTON—If there is one fact that Marianne Elliott, chair of the U.S. Military Cancer Institute (USMCI) Institutional Review Board (IRB), wants investigators to know, it is that the USMCI’s new cancer research review board is “open for business.”

The USMCI IRB held its inaugural meeting at National Naval Medical Center to review oncology research protocols in February. The new IRB offers a one-stop shop for researchers to have oncology research protocols reviewed.

“We are interested in trying to be an IRB that can help an investigator who wants to take one protocol and put it in three, four, five, or 10 places and have one IRB review, rather than 10 different IRBs from each of those institutions,” explained Elliott, even if the collaboration is with a non-DoD medical center. While the USMCI IRB is focused on multisite investigations, it can also do
reviews for single-site investigations.

Typically, DoD investigators who want to pursue a research project at multiple institutions would need to go to each institution for IRB approval. That option is still available. However, the advantage of using the USMCI IRB is that by taking the protocol to one central IRB rather than multiple IRBs, it is expected to save the researchers time, Elliott explained.

“Individual sites can still look at protocols,” she said. “This isn’t mandatory. It is voluntary. I think investigators who particularly want to put a trial into several places may really want to consider this because, if they don’t, then likely they will have to go through [multiple] IRBs.”

IRB Review

Central IRBs are not necessarily new to the civilian or military research community, but this is the first one to review cancer research in DoD. A central infectious disease IRB already is located at the Uniformed Services University of the Health Sciences that supports multisite DoD infectious disease research. Elliott also pointed out that the HQ United States Army Medical Research and Materiel Command IRB currently serves as a central IRB for multi-site research protocols involving hyperbaric oxygen in mTBI treatment and is planning to expand its scope.

Elliott acknowledged that institutions may be reluctant to rely on a central IRB that is not within their own institution, which is why she is interested in educating the research community about this new option for oncology investigations.

“Over the past years, people have been working very hard to…break down the barriers and misperceptions that when you outsource that piece of your research protection program, that somehow you lose control and somehow there are things that might happen that you would be held accountable for that you aren’t doing. We have worked over the years to dispel those urban legends,” she said.

Reviewing Protocols

The USMCI IRB can review protocols for all types of cancers, Elliott explained, but the process must start within the investigator’s own institution.

Researchers who have proposals they want the USMCI IRB to review must go through their local institution for support to do that and to facilitate the process. When an proposal is approved by the USMCI IRB, notice will go back to that institution, and the researcher will then be granted permission to start the research.

To make sure they are handling the reviews in a timely manner, Elliott said USMCIRB is tracking its timelines. In addition, investigators are being asked to fill out a satisfaction survey after reviews.

“We don’t have any of that [data] now because we have only reviewed two protocols,” she said. “We do plan to do that because I think IRBs don’t do that, and I think it is something they need to be doing.”

Right now, she said the program is working hard to get the word out about its existence. Investigators and institutions who would like more information can go to

back to May articles

Related Articles

New Agents Extend Options for Increased Survival in Metastatic Prostate Cancer

Accounting for nearly a third of all cancer diagnoses, prostate cancer is the most frequently diagnosed cancer in the VHA, where past research has suggested that the malignancy is caught earlier than in other healthcare systems.

Personalized Medicine Brightens Outlook for Most Common Kidney Cancer

In the past five years, 10 new system therapies have been approved for renal cell carcinoma (RCC), the most common type of kidney cancer.

U.S. Medicine Recommends

More From department of defense dod

Department of Defense (DoD)

Automation Speeds Results and Increases Accuracy for Point-of-Care Testing at Walter Reed NMMC

With a long history of point of care testing at both of its predecessor organizations, the Walter Reed National Military Medical Center (WRNMMC) laboratory services staff were keenly aware of the advantages of using portable testing devices to obtain rapid patient assessments.

Department of Defense (DoD)

High Rate of Pectoralis Tears Among Deployed Servicemembers Lifting Weights

Lifting weights is one way servicemembers keep in peak physical condition during deployment.

Department of Defense (DoD)

DoD Study Finds That Type 2 Diabetes Increases Breast Cancer Mortality

Having Type 2 diabetes mellitus (DM-2) increases mortality risk in breast cancer patients, regardless of whether diabetes was diagnosed before or after breast cancer, according to a recent study.

Department of Defense (DoD)

Now Hear This: Otolaryngologist Leads Effort to Prevent Auditory Issues

Among those who are exposed to combat, it’s the weapons fire that does it. In the Navy, it’s the noise levels in engine rooms and on the decks of carriers.

Department of Defense (DoD)

GAO: ‘Gaps’ in MHS Physician Specialties Could Affect Wartime Readiness

WASHINGTON — The military services need to develop “targeted and coordinated strategies” to alleviate military physician gaps, a recent report recommended.

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up